New Data Reveal Molecular Drivers of Thyroid Eye Disease (TED) May Remain Activated In Patients with

-- Oral presentation at AAO 2022 suggests IGF-1 and its related pathways are extensively upregulated throughout all stages of TED --DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced the presentation of new data defining molecular patterns in TED and further implicating the role of insu...

Related Keywords

United States ,Jules Stein Eye Institute ,California ,Los Angeles ,Chicago ,Illinois ,American ,Jeffreyw Sherman ,Tina Ventura ,Shoaib Ugradar ,Rachel Vann ,Instagram ,Product Communications ,Linkedin ,Twitter ,Visa ,American Academy Of Ophthalmology ,Nasdaq ,American Academy Of Ophthalmology Annual Meeting ,European Group On Grave Orbitopathy ,Facebook ,Horizon Therapeutics ,American Academy ,Ophthalmology Annual Meeting ,Thyroid Eye Disease ,Genome Transcriptome Comparison ,Chronic Thyroid Eye Disease ,Thyroid Associated ,Grave Disease Is Mediated Through ,Insulin Like Growth Factor ,Grave Orbitopathy ,Clinical Practice Guidelines ,Medical Management ,European Group ,Vice President ,Chief Investor Relations Officer ,